Neuroscience and Behavioral Physiology

, Volume 33, Issue 8, pp 799–804 | Cite as

Status of the “Protein Kinase CK2–HMG14” System in Age-Related Amnesia in Rats

  • B. A. Reikhardt
  • O. G. Kulikova
  • G. Yu. Borisova
  • I. Ya. Aleksandrova
  • N. S. Sapronov


The experiments described here demonstrate that disruption of the phosphorylation of transcription factors of the HMG cAMP/Ca-independent protein kinase CK2 class may be the cause of decreased gene expression in age-related cognitive deficits. Amnesia for a conditioned passive avoidance reaction (CPAR) in aged rats (24 months old) was accompanied by decreases in the synthesis of synaptosomal proteins and transcription in nuclei isolated from cortical, hippocampal, and striatal neurons. There was a decrease in chromatin protein kinase CK2 activity and a significant decrease in the phosphorylation of HMG14 by protein kinase CK2. Selective activators of protein kinase CK2 (1-ethyl-4-carbamoyl-5-methylcarbamoylimidazole and 1-ethyl-4,5-dicarbamoylimidazole) increased HMG14 phosphorylation by protein kinase CK2, increased transcription, increased the synthesis of synaptosomal proteins, and decreased amnesia for the CPAR in aged rats. Thus, activation of the “protein kinase CK2–HMG14” system is accompanied by optimization of synaptic plasticity in aged animals. The results provide evidence for the high therapeutic potential of protein kinase CK2 activators.

brain aging amnesia gene expression protein kinase CK2 transcription factors HMG14 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    É. Vingender, “Classification of eukaryotic transcription factors, ” Mol. Biol., 31, No. 4, 584–600 (1997).Google Scholar
  2. 2.
    O. G. Kulikova, L. M. Belyavtseva, B. A. Reikhardt, et al., “Involvement of RNA synthesis in the process of acquisition and retention of conditioned reflexes. (Studies using antifeins), ” Zh. Vyssh. Nerv. Deyat., 42, No. 4, 687–691 (1992).Google Scholar
  3. 3.
    O. G. Kulikov and B. A. Reikhardt, “HMG14 – a physiological substrate for neuron chromatin casein kinase NII, ” Biokhimiya, 62, No. 6, 1046–1054 (1996).Google Scholar
  4. 4.
    O. G. Kulikov and B. A. Reikhardt, “The role of autophosphorylation in controlling the activity of neuron chromatin protein kinase KK2 in rats, ” Biokhimiya, 63, No. 12, 1646–1653 (1998).Google Scholar
  5. 5.
    O. G. Kulikov, B. A. Reikhardt, and N. S. Sapronov, “Involvement of the genetic apparatus in the mechanisms of trace formation: the role of the calcium-regulatory system of neurons in rats, ” Zh. Vyssh. Nerv. Deyat., 47, No. 4, 708–714 (1997).Google Scholar
  6. 6.
    B. A. Reikhardt, O. G. Kulikov, and N. S. Sapronov, “Dynamics of lesions to the regulatory systems of the brain in age-related amnesia in rats, ” Psikhofarmakol. Biol. Narkol., 1, 38–42 (2001).Google Scholar
  7. 7.
    N. A. Fedorova, “High-mobility proteins: structure, location, function, ” Biokhimiya, 50, No. 5, 9–18 (1991).Google Scholar
  8. 8.
    P. D. Shabanov and Yu. S. Borodkin, Memory Impairments and Their Correction [in Russian], Nauka, Leningrad (1989).Google Scholar
  9. 9.
    C. M. Alberini, M. Chirardi, R. Metz, and E. R. Kandel, “C/EBP is an immediate-early gene required for the consolidation of long-term facilitation in Aplysia, ” Cell, 76, No. 6, 1099–1114 (1994).Google Scholar
  10. 10.
    D. L. Alkon and T. J. Nelson, “Specificity of molecular changes in neurons involved in memory storage, ” FASEB J., 4, No. 10, 1567–1576 (1990).Google Scholar
  11. 11.
    J. E. Allende and C. C. Allende, “Protein kinase CK2: an enzyme with multiple substrates and a puzzling regulation, ” FASEB J., 9, No. 3, 313–323 (1995).Google Scholar
  12. 12.
    P. R. Blanquet, “Neurotrophin-induced activation of casein kinase II in rat hippocampal slices, ” Neurosci., 86, 739–749 (1998).Google Scholar
  13. 13.
    M. Bustin, L. Trieschmann, and Y. V. Postnikov, “The HMG14/17 chromosomal protein family: architectural elements that enhance transcription from chromatin templates, ” Semin. Cell. Biol., 6, No. 4, 247–255 (1995).Google Scholar
  14. 14.
    T. J. Carew, “Molecular enhancement of memory formation, ” Neuron, 16, No. 1, 5–8 (1996).Google Scholar
  15. 15.
    C. Charriant-Marlangue and S. Otani, “Rapid activation of hippocampal casein kinase during long-term potentiation, ” Proc. Natl. Acad. Sci. USA, 88, 10232–10236 (1996).Google Scholar
  16. 16.
    J. Diaz-Nido, K. Mizuno, H. Nawa, and D. R. Marshak, “Regulation of protein kinase CK2 isoform expression during rat brain development, ” Cell. Mol. Biol. Res., 40, No. 5–6, 581–585 (1994).Google Scholar
  17. 17.
    U. Frey, S. Frey, F. Schollmeier, and M. Krug, “Influence of actinomycin D, a RNA synthesis inhibitor, on long-term potentiation in rat hippocampal neurons in vivo and in vitro, ” J. Physiol. (London), 490, No. 3, 703–711 (1996).Google Scholar
  18. 18.
    K. S. Haviryaji and M. C. Vemuri, “Effect of ethanol on nuclear casein kinase II activity in brain, ” Neurochem. Res., 22, No. 6, 699–704 (1997).Google Scholar
  19. 19.
    L. W. Jin and T. Saitoh, “Changes in protein kinases in brain aging and Alzheimer's disease. Implication for drug therapy, ” Drugs-Aging, 6, No. 2, 136–149 (1995).Google Scholar
  20. 20.
    M. Karin and T. Hunter, “Transcriptional control by protein phosphorylation: signal transmission from the cell surface to the nucleus, ” Current Biol., 5, 747–757 (1995).Google Scholar
  21. 21.
    D. N. Liverman and I. Mody, “Casein kinase-II regulates NMDA channel function of hippocampal neurons, ” Nature Neurosci., 2, No. 2, 125–132 (1995).Google Scholar
  22. 22.
    L. A. Pinna, “Protein kinase CK2, ” Int. J. Biochem. Cell Biol., 29, No. 4, 551–554 (1997).Google Scholar
  23. 23.
    S. I. S. Rattan, “Synthesis, modifications, and turnover of proteins during aging, ” Exptl. Gerontol., 31, No. 1–2, 33–47 (1996).Google Scholar
  24. 24.
    K. Yasojima, J. Kuret, A. J. DeMaggio, E. McGeer, and P. L. McGeer, “Casein kinase I delta mRNA in upregulated in Alzheimer's disease brain, ” Brain Res., 865, 116–200 (2000).Google Scholar

Copyright information

© Plenum Publishing Corporation 2003

Authors and Affiliations

  • B. A. Reikhardt
    • 1
  • O. G. Kulikova
    • 1
  • G. Yu. Borisova
    • 1
  • I. Ya. Aleksandrova
    • 1
  • N. S. Sapronov
    • 1
  1. 1.Science Research Institute of Experimental Medicine, Russian Academy of Medical SciencesSt. PetersburgRussia

Personalised recommendations